Cargando…

Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach

BACKGROUND: In the last couple of years, viral infections have been leading the globe, considered one of the most widespread and extremely damaging health problems and one of the leading causes of mortality in the modern period. Although several viral infections are discovered, such as SARS CoV-2, L...

Descripción completa

Detalles Bibliográficos
Autores principales: Akash, Shopnil, Hossain, Arafat, Hossain, Md. Sarowar, Rahman, Md. Mominur, Ahmed, Mohammad Z., Ali, Nemat, Valis, Martin, Kuca, Kamil, Sharma, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073709/
https://www.ncbi.nlm.nih.gov/pubmed/37033493
http://dx.doi.org/10.3389/fcimb.2023.1157627
_version_ 1785019629082509312
author Akash, Shopnil
Hossain, Arafat
Hossain, Md. Sarowar
Rahman, Md. Mominur
Ahmed, Mohammad Z.
Ali, Nemat
Valis, Martin
Kuca, Kamil
Sharma, Rohit
author_facet Akash, Shopnil
Hossain, Arafat
Hossain, Md. Sarowar
Rahman, Md. Mominur
Ahmed, Mohammad Z.
Ali, Nemat
Valis, Martin
Kuca, Kamil
Sharma, Rohit
author_sort Akash, Shopnil
collection PubMed
description BACKGROUND: In the last couple of years, viral infections have been leading the globe, considered one of the most widespread and extremely damaging health problems and one of the leading causes of mortality in the modern period. Although several viral infections are discovered, such as SARS CoV-2, Langya Henipavirus, there have only been a limited number of discoveries of possible antiviral drug, and vaccine that have even received authorization for the protection of human health. Recently, another virial infection is infecting worldwide (Monkeypox, and Smallpox), which concerns pharmacists, biochemists, doctors, and healthcare providers about another epidemic. Also, currently no specific treatment is available against Monkeypox. This research gap encouraged us to develop a new molecule to fight against monkeypox and smallpox disease. So, firstly, fifty different curcumin derivatives were collected from natural sources, which are available in the PubChem database, to determine antiviral capabilities against Monkeypox and Smallpox. MATERIAL AND METHOD: Preliminarily, the molecular docking experiment of fifty different curcumin derivatives were conducted, and the majority of the substances produced the expected binding affinities. Then, twelve curcumin derivatives were picked up for further analysis based on the maximum docking score. After that, the density functional theory (DFT) was used to determine chemical characterizations such as the highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), softness, and hardness, etc. RESULTS: The mentioned derivatives demonstrated docking scores greater than 6.80 kcal/mol, and the most significant binding affinity was at -8.90 kcal/mol, even though 12 molecules had higher binding scores (-8.00 kcal/mol to -8.9 kcal/mol), and better than the standard medications. The molecular dynamic simulation is described by root mean square deviation (RMSD) and root-mean-square fluctuation (RMSF), demonstrating that all the compounds might be stable in the physiological system. CONCLUSION: In conclusion, each derivative of curcumin has outstanding absorption, distribution, metabolism, excretion, and toxicity (ADMET) characteristics. Hence, we recommended the aforementioned curcumin derivatives as potential antiviral agents for the treatment of Monkeypox and Smallpox virus, and more in vivo investigations are warranted to substantiate our findings.
format Online
Article
Text
id pubmed-10073709
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100737092023-04-06 Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach Akash, Shopnil Hossain, Arafat Hossain, Md. Sarowar Rahman, Md. Mominur Ahmed, Mohammad Z. Ali, Nemat Valis, Martin Kuca, Kamil Sharma, Rohit Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: In the last couple of years, viral infections have been leading the globe, considered one of the most widespread and extremely damaging health problems and one of the leading causes of mortality in the modern period. Although several viral infections are discovered, such as SARS CoV-2, Langya Henipavirus, there have only been a limited number of discoveries of possible antiviral drug, and vaccine that have even received authorization for the protection of human health. Recently, another virial infection is infecting worldwide (Monkeypox, and Smallpox), which concerns pharmacists, biochemists, doctors, and healthcare providers about another epidemic. Also, currently no specific treatment is available against Monkeypox. This research gap encouraged us to develop a new molecule to fight against monkeypox and smallpox disease. So, firstly, fifty different curcumin derivatives were collected from natural sources, which are available in the PubChem database, to determine antiviral capabilities against Monkeypox and Smallpox. MATERIAL AND METHOD: Preliminarily, the molecular docking experiment of fifty different curcumin derivatives were conducted, and the majority of the substances produced the expected binding affinities. Then, twelve curcumin derivatives were picked up for further analysis based on the maximum docking score. After that, the density functional theory (DFT) was used to determine chemical characterizations such as the highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), softness, and hardness, etc. RESULTS: The mentioned derivatives demonstrated docking scores greater than 6.80 kcal/mol, and the most significant binding affinity was at -8.90 kcal/mol, even though 12 molecules had higher binding scores (-8.00 kcal/mol to -8.9 kcal/mol), and better than the standard medications. The molecular dynamic simulation is described by root mean square deviation (RMSD) and root-mean-square fluctuation (RMSF), demonstrating that all the compounds might be stable in the physiological system. CONCLUSION: In conclusion, each derivative of curcumin has outstanding absorption, distribution, metabolism, excretion, and toxicity (ADMET) characteristics. Hence, we recommended the aforementioned curcumin derivatives as potential antiviral agents for the treatment of Monkeypox and Smallpox virus, and more in vivo investigations are warranted to substantiate our findings. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073709/ /pubmed/37033493 http://dx.doi.org/10.3389/fcimb.2023.1157627 Text en Copyright © 2023 Akash, Hossain, Hossain, Rahman, Ahmed, Ali, Valis, Kuca and Sharma https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Akash, Shopnil
Hossain, Arafat
Hossain, Md. Sarowar
Rahman, Md. Mominur
Ahmed, Mohammad Z.
Ali, Nemat
Valis, Martin
Kuca, Kamil
Sharma, Rohit
Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title_full Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title_fullStr Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title_full_unstemmed Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title_short Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
title_sort anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073709/
https://www.ncbi.nlm.nih.gov/pubmed/37033493
http://dx.doi.org/10.3389/fcimb.2023.1157627
work_keys_str_mv AT akashshopnil antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT hossainarafat antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT hossainmdsarowar antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT rahmanmdmominur antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT ahmedmohammadz antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT alinemat antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT valismartin antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT kucakamil antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach
AT sharmarohit antiviraldrugdiscoveryagainstmonkeypoxandsmallpoxinfectionbynaturalcurcuminderivativesacomputationaldrugdesignapproach